| Species | Cell type | Surface markers | References |
| Human | NPSPCs | CD73+, CD90+, CD105+, CD29-CD45- | Qi et al., 2019 [115] | Human | NPSPCs | CD73+, CD90+, CD105+, CD34-, CD45-, HLA-DR- | Liu et al., 2017 [71] | Human | NPSPCs | CD73+, CD90+, CD105+, CD34-, CD45- | Chen et al., 2016 [116] | Human | NPSPCs | Tie2+, GD2+, Flt1+, CD271+, CD24- | Sakai et al., 2012 [23] | Human | NPSPCs | CD90+, CD73+, CD105+, CD106+, CD166+, CD14-, CD19-, CD24-, CD34-, CD45-, HLA-DR- | Blanco et al., 2010 [117] | Human | NPSPCs | CD29+, CD44+, CD105+, CD14-, CD34-, CD45-, HLA-DR- | Shen et al., 2015 [25] | Human | NPSPCs | Tie2+, GD2+, Nanog+, Oct-4+, Sox-2+ | Li et al., 2017 [118] | Rat | NPSPCs | CD73+, CD90+, CD105+, CD34-, CD45- | Zhao et al., 2017 [119] | Canine | NPSPCs | CD133+, KI67+, Nanog+, NCAM+, Nestin+, Oct3/4+, Sox2+, Brachyury- | Erwin et al., 2013 [42] | Human | NPSPCs, AFSPCs | CD49a+, CD63+, CD73+, CD90+, CD105+, CD166+, p75 NTR+, CD133/1+, CD34- | Risbud et al., 2007 [39] | Rhesus macaque | NPSPCs, AFSPCs | CD44+, CD90+, CD146+, CD166+, HLA-DR+, CD271-, CD106-, CD29- | Huang et al., 2013 [120] | Rabbit | NPSPCs, AFSPCs | PCNA+, CD166+, C-kit+, Jagged1+, Notch1+ | Yasen et al., 2013 [121] | Human, rat, rabbit | AFSPCs | Notch1+, Delta4+, CD117+, STRO-1+, C-kit low, KI67 low | Henriksson et al., 2009 [40] Henriksson et al., 2012 [41] | Human | AFSPCs | CD29+, CD49e+, CD51+, CD73+, CD90+, CD105+, CD166+, CD184+, CD24+, Stro-1+, Nestin+, NSE+, CD31-, CD34-, CD45-, CD106-, CD117-, CD133- | Feng et al., 2010 [122] | Human | AFSPCs | CD14+, CD29+, CD44+, CD73+, CD90+, CD105+, STRO-1+, CD34-, CD45- | Gruber et al., 2016 [123] | Rabbit | AFSPCs | CD29+, CD44+, CD166+, Oct4+, Nucleostemin+, SSEA-4+, CD4-, CD8-, CD14- | Guo et al., 2018 [124] | Rabbit | AFSPCs | CD29+, CD44+, CD166+, Oct4+, SSEA-4+, CD4-, CD8-, CD14- | Liu et al., 2014 [125] | Human | CEPSCs | CD73+, CD90+, CD105+, CD34-, CD45-, HLA-DR- | Yuan et al., 2018 [126] Yao et al., 2016 [127] | Human | CEPSCs | CD44+, CD73+, CD90+, CD105+, CD133+, CD166+, Stro-1+, CD14-, CD19-, CD34-, CD45-, HLA-DR- | Liu et al., 2011 [45] Huang et al., 2012 [50] |
|
|